FMP
LENSAR, Inc.
LNSR
NASDAQ
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
3.23 USD
0.09 (2.79%)
About
ceo
Mr. Nicholas T. Curtis
sector
Healthcare
industry
Medical - Devices
website
https://www.lensar.com
exchange
NASDAQ
Description
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
CIK
0001320350
ISIN
US52634L1089
CUSIP
52634L108
Address
2800 Discovery Drive
Phone
888 536 7271
Country
US
Employee
130
IPO Date
Oct 2, 2020
Summary
CIK
0001320350
Exchange
NASDAQ
Industry
Medical - Devices
Sector
Healthcare
CUSIP
52634L108
ISIN
US52634L1089
Country
US
Price
3.23
Beta
0.47
Volume Avg.
41.53k
Market Cap
36.81M
Shares
-
52-Week
1.8-5.3
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-2.47
P/B
-
Website
https://www.lensar.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest LNSR News
It looks like there's no news available.
